ScRNA-Seq and BCR Analysis of Murine Immune Responses to Inactivated DHAV-1 as a Model Antigen
Viruses · 08.04.2026 · 18 (4) · 448
DOI: 10.3390/v18040448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 08.04.2026. Verfasst von Yaru Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China. Hauptthemen laut MEDLINE: Receptors, Antigen, B-Cell, Antigens, Viral. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Key Research and Development Program of Shandong Province, Key Research and Development Program of Shandong Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Currently, the B-cell response patterns induced by viral antigens in avian disease models and their detailed immunological characteristics still require comprehensive elucidation at the single-cell level. In this study, we employed single-cell sequencing (scRNA-seq) and B cell library technology to conduct an in-depth analysis of B cells in the spleens of mice with inactivated duck hepatitis A virus type 1 (DHAV-1) as model antigen. This study aimed to investigate the immunological characteristics of the virus antigen in the mouse model and characteristics of B-Cell Receptors. The results showed that the DHAV-1 group had distinct changes in splenic B cell subset counts, proportions, and intercellular communication. Additionally, an increased trend in communication strength between Gm26917+B and Gm11837+B cells was observed, with enriched expression of C-X-C motif chemokine ligand (CXCL) and lymphotoxin (LT) detected in the DHAV-1 group. Furthermore, the DHAV-1 group exhibited a prominent combination of the IGHV1 family and IGHV3-1/IGHJ3 in the heavy (H) chain variable region. Compared with the CK group (negative control group), the amino acid sequence length and diversity of the CDR3 region in the DHAV-1 group exhibited a decreasing trend. In summary, our findings characterize the immunological features of splenic B cells in mice after immunization with inactivated DHAV-1, and provide a preliminary characterization of DHAV-1-induced B cell transcriptional states and BCR repertoire features, generating testable hypotheses for subsequent mechanistic investigations of B cell-mediated immune responses to viral antigens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China.
- Institute of Animal Science, Chinese Academy of Agricultural Sciences, 2, Yuanmingyuan West Road, Beijing 100091, China.
Förderung
- This study was supported by the Key Research and Development Program of Shandong Province
- Key Research and Development Program of Shandong Province
- National Key Research and Development Program of China
- Open Project of State Key Laboratory of Animal Biotech Breeding
- Innovation Leading Team Program of Guangzhou City
- China Agriculture Research System of MOF and MARA
- Project Charter for the Shandong Provincial Key Research and Development Program in Agricultural Breeding Engineering
Zitieren
APA
Fan, Y., Zhao, S., Qin, Y., Liu, G., Cui, L., Zhu, S., Diao, Y., He, D., & Tang, Y. (2026). ScRNA-Seq and BCR Analysis of Murine Immune Responses to Inactivated DHAV-1 as a Model Antigen. Viruses, 18(4), 448. https://doi.org/10.3390/v18040448
Vancouver
Fan Y, Zhao S, Qin Y, Liu G, Cui L, Zhu S, et al. ScRNA-Seq and BCR Analysis of Murine Immune Responses to Inactivated DHAV-1 as a Model Antigen. Viruses. 2026;18(4):448. doi:10.3390/v18040448
BibTeX
@article{Fan2026,
author = {Fan, Yaru and Zhao, Saisai and Qin, Yafei and Liu, Guocheng and Cui, Linyu and Zhu, Siming and Diao, Youxiang and He, Dalin and Tang, Yi},
title = {ScRNA-Seq and BCR Analysis of Murine Immune Responses to Inactivated DHAV-1 as a Model Antigen},
journal = {Viruses},
year = {2026},
volume = {18},
number = {4},
pages = {448},
doi = {10.3390/v18040448}
}
EUVIMED